ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Share ownership Zhongzhi Pharmaceutical Holdings Limited

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:11 19/09/2024 pm IST			5-day change	1st Jan Change
0.9000 ^HKD	+2.27%		+7.14%	-36.62%

09/09	Zhongzhi Pharmaceutical Holdings Limited Announces Resignation of Peng Zhiyun as Non-Executive Director	CI
23/08	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Share class: Zhongzhi Pharmaceutical Holdings Limited

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	863,600,000	209,333,600 ( 24.24 %)	0	24.24 %

Major shareholders: Zhongzhi Pharmaceutical Holdings Limited

Name	Equities	%	Valuation
Zhi Tian Lai 60.33 %	521,008,800	60.33 %	63 M $
Li Xia Jiang 4.891 %	42,240,000	4.891 %	5 M $
Ying Feng Lai 0.6936 %	5,990,000	0.6936 %	729 522 $
Xiao Jun Cao 0.3750 %	3,238,600	0.3750 %	394 429 $
Zhi Yun Peng 0.1425 %	1,231,000	0.1425 %	149 923 $

Breakdown by shareholder type

Individuals	66.43%
Unknown	33.57%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals

66.43%

Based on 1000 largest holdings

Zhongzhi Pharmaceutical Holdings Ltd is a China-based investment holding company. The Company is principally engaged in the research and development, manufacturing and sales of Chinese patent medicines and decoction pieces (consisting of traditional decoction pieces and modern decoction pieces). The Company operates through three segments: pharmaceutical manufacturing segment, operation of chain pharmacies in Zhongshan, Guangdong Province and operation of on-line pharmacies. The Companyâs brands include Zeus, Liumian and Caojinghua. The Company mainly conducts its businesses in the domestic market.

Employees

2,736

Sector

Pharmaceuticals

Calendar

20/03/2025 - Q4 2024 Earnings Release (Projected)

More about the company